Kidneeds is a not-for-profit corporation dedicated to the study of Dense Deposit Disease (DDD). DDD is a type of C3 glomerulopathy (C3G). It is caused
by dysregulation of the alternative pathway of complement. About
half of people with DDD progress to end stage renal failure disease
(ESRD) within 10 years of diagnosis. Transplant recipients face
disease recurrence in their allografts.
Kidneeds' goal is to stimulate research that will lead to an effective treatment for DDD. Kidneeds is striving to achieve this goal by funding scientists to study DDD.
Kidneeds is also an educational resource for patients and healthcare providers.
Patients and their families can help us learn more about DDD by completing the:
MPGN Database Survey
This survey collects epidemiological data on persons with DDD and C3 glomerulonephritis (C3GN), another type of C3G.